Robert Lee
Podiatrist · Tulsa, OKNPI 1114941820
Payments from drug & device makers
What this record shows
This record is dominated by education: $972 of the $1,579 with a category attached, or 61.6%. Pylant Medical accounts for 61.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $989 and has fallen 87.2% since, to $126 in 2025. That places this record below the midpoint for podiatrist clinicians in OK, where the typical reported total is $1,579.
Across 29 payments — averaging $54.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$972
- Paratek Pharmaceuticals, Inc.$470
- Solventum Corporation$54
- Smith+Nephew$35
- Bioventus LLC$18
- Melinta Therapeutics, LLC$17
- plus $12 from 1 others
What the payments were for
- Food & beverage$60738%
- Education$97262%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 1 | $972 |
| Paratek Pharmaceuticals, Inc. | 22 | $470 |
| Solventum Corporation | 1 | $54 |
| Smith+Nephew | 2 | $35 |
| Bioventus LLC | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $17 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$118
How this compares
$1,579 in reported general payments places this provider in the 50th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CefuroximeCefuroxime Axetil | 27 | $766 |
| Ammonium Lactate | 23 | $564 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 54 | $483 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 40 | $370 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $265 |
| Ciprofloxacin Hcl | 14 | $156 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Tulsa
- Kevin QuangTulsa$3K
- Lisa MogelnickiTulsa$2K
- Mark NahmiasTulsa$1K
- Lauren GiddensTulsa$861
- Allison IskiTulsa$666
- Timothy MaclinTulsa$360
- David CavallaroOklahoma City$22K
- Ahmed BukshEdmond$17K
- Aerial AveryAda$13K
- Patricia BoehleOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.